31 studies found for: " July 23, 2008":" August 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA.
Women-Focused HIV Prevention in the Western Cape
TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Online Social Networking for HIV Prevention
Pregnant Women's CoOp
Cognitive Behavioral Stress Management for HIV+ Drug Abusers
Evaluation of Open-canal Behind-the-Ear Hearing Aids and Traditional In-the-ear Hearing Aids.
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
ABT-888 With Cyclophosphamide and Doxorubicin in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
† Indicates status has not been verified in more than two years